{"messages":[{"status":"ok","category":null}], "collection":[{"title":"Wearable-based sleep and activity tracking detects Parkinson's disease and associated pathological hallmarks","authors":"Moustaklis, A.; Gerasimou, I.; Sotirakis, C.; Chairta, P.; Kurtis, M. M.; Del Campo, N.; Feige, T.; Schnalke, N.; Almarcha Menargues, M.-L.; Michailidou, K.; Christodoulou, K.; Fabbri, M.; Falkenburger, B. H.; Hadjileontiadis, L.; Hadjidimitriou, S.","author_corresponding":"Stelios Hadjidimitriou","author_corresponding_institution":"Department of Electrical and Computer Engineering, Faculty of Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece","doi":"10.64898\/2026.11.13.26367931","date":"2026-11-15","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/11\/15\/2026.11.13.26367931.source.xml","abstract":"Parkinson's disease (PD) is associated with sleep and motor function impairment, even in the early stages. Here, we investigated whether passive wearable-based sleep and activity tracking can detect PD and its associated pathological hallmarks, dopaminergic deficit and -synuclein pathology. Sleep and activity metrics (SAM) were derived from free-living wrist accelerometry data of a U.S. cohort and used to train a machine learning model (SAM-PD) to distinguish persons with PD (n = 133) from healthy controls (n = 26). The model achieved an AUROC of 0.93 and an AUPRC of 0.98, demonstrated excellent test-retest reliability, and generalized without retraining to an independent European cohort (n = 40; 50% PwPD) monitored with a different device (AUROC, 0.95; AUPRC, 0.95). REM sleep duration, walking cadence, and low-level acceleration features were most predictive. Applied to a U.S. at-risk cohort, SAM-PD performed comparably to the resource-intensive Movement Disorder Society (MDS) prodromal PD risk score in detecting dopaminergic deficit (AUROC, 0.86 vs. 0.80; AUPRC, 0.45 vs. 0.46; n = 121; 12.4% prevalence) and -synuclein pathology (AUROC, 0.76 for both; AUPRC 0.50 vs. 0.42; n = 114; 16.7% prevalence). A combination with the MDS score modestly improved detection. Findings support further evaluation of wearable monitoring for PD screening and biomarker enrichment in larger populations.","funder":"NA","published":"NA","server":"medRxiv"}]}



